Adherence to Oral Eye Supplements: General Principles and Practical Strategies
Abstract Adherence to oral therapies, including eye-targeted nutritional supplements, is a pervasive challenge in chronic disease management, with typical adherence rates for long-term medications ...
Patients, AREDS2 Supplements, and Real‑World Adherence
Abstract AREDS and AREDS2 established that high-dose antioxidant vitamins, zinc, copper, lutein, and zeaxanthin reduce progression to advanced age-related macular degeneration (AMD) in patients wit...
Mitochondrial Dysfunction in Retinal Aging and Age-Related Macular Degeneration
Abstract Mitochondria are essential for retinal cell survival, providing ATP for phototransduction and ion homeostasis while regulating redox balance, calcium signalling, and apoptosis.(1,2) The ne...
Oxidative Stress and Retinal Aging
Abstract The retina is one of the most metabolically active tissues in the body, characterized by high oxygen consumption, abundant mitochondria, continuous exposure to visible light, and a high co...
Macular Pigment Optical Density (MPOD) Explained: Biology, Measurement, and Clinical Relevance
Abstract Macular pigment optical density (MPOD) quantifies the concentration of macular xanthophyll carotenoids—primarily lutein, zeaxanthin, and meso‑zeaxanthin—in the central retina.(1,2) These p...
AREDS vs AREDS2: What Changed and Why
Abstract The original Age-Related Eye Disease Study (AREDS) established that high-dose antioxidant vitamins (vitamin C, vitamin E, β‑carotene) plus zinc and copper reduced the 5‑year risk of progre...